-
Hi! Welcome to Gender Analysis, a web series offering an in-depth look at transgender issues in society. We're Zinnia Jones and Heather McNamara, and we're the Gender Analysis team!
Featured Post
Depersonalization in gender dysphoria: widespread and widely unrecognized
It’s a sense of unreality, estrangement from your own feelings, and separation from the real world – and it’s a common symptom of gender dysphoria.Support the Blog
-
Recent Posts
- “Still dreaming of running over the trans activists”: Sharon Beck, leader of anti-trans parent group Cardinal Support Network and wife of SEGM’s cofounder, “guided” Ohio Rep. Gary Click on his trans care ban
- Counterpoint: Ohio trans youth care ban veto was a victory for a gatekeeping surveillance state targeting trans adults
- New trial exhibits in Doe v. Ladapo: DOH worked with Genspect leaders Stella O’Malley and Joe Burgo in July 2022; Hilary Cass met SEGM’s Patrick Hunter to discuss Florida’s anti-trans report; Jamie Reed’s attorney Vernadette Broyles chose the lineup of detransitioners speaking at the Board of Medicine
- The Observer gets it wrong: Anti-gay and anti-trans conversion practices have always appealed to “fluidity” of both sexual orientation and gender identity
- Mask off, mask on: Kathleen Goonan, advisor to SEGM and Genspect, taught Moms for Liberty to “play a dual game” and pretend to support parents who accept their trans kids. Then she pretended to support these parents on a podcast with Genspect’s founder.
Topics
- Academia (1)
- Adult care restrictions (2)
- American College of Pediatricians (5)
- Anti-trans detransitioners (1)
- Antiandrogens (5)
- Are You Asking Why? Collective (1)
- Autism (5)
- Awareness building (14)
- Bathrooms and public accommodations (12)
- Biology of transition (23)
- Book reviews (7)
- Breast (15)
- Cardinal Support Network (1)
- Catholic Church (10)
- Catholic Medical Association (1)
- CCV (1)
- Community (2)
- Conversion practices (6)
- COVID-19 (12)
- Dekker v. Weida (6)
- Depersonalization (22)
- Dermatology (4)
- Doe v. Ladapo (2)
- EBM (1)
- Endocrinology (69)
- Ethics (30)
- Faith and religion (18)
- Family (9)
- Feminism (6)
- Fertility and reproduction (7)
- Florida (16)
- Gary Click (1)
- Gatekeeping (2)
- Gender Analysis (4)
- Gender dysphoria (66)
- Gender Exploratory Therapy Association (4)
- Genetics (1)
- Genspect (5)
- Health care (49)
- Heritage Foundation (2)
- History (19)
- HIV/AIDS (2)
- Hoaxes (45)
- Influence groups (6)
- Informed consent (1)
- Law (8)
- Litigation (1)
- Media (46)
- Methodology (1)
- Military (2)
- Misinformation (3)
- Moms for Liberty (1)
- More Trans (4)
- National Catholic Bioethics Center (1)
- News (24)
- Nonbinary (8)
- Ohio (2)
- Ohio administrative rules (2)
- Oncology (15)
- Outcomes of transition (50)
- Parents of ROGD Kids (1)
- Parents of ROGD Kids Ohio (1)
- Perception and cognitive science (3)
- Personal (32)
- Philosophy and language (16)
- Politics (5)
- Politics and law (40)
- Privacy (1)
- Progestogens (11)
- Psychology and psychiatry (36)
- Psychotherapy (2)
- Rapid onset gender dysphoria (3)
- Regret and detransition (21)
- Replies (31)
- Rhetoric (12)
- Right wing (2)
- Safety data (4)
- SB 254 (2)
- Schools (1)
- SEGM (5)
- Sexuality (26)
- Sharon Beck (1)
- Sociological research (28)
- Statistics and demographics (28)
- Stephen Beck (1)
- Surgery (22)
- Surveillance (1)
- TERFs (1)
- Trans youth (98)
- Transfeminine (12)
- Transgender medicine (94)
- Transmasculine (16)
- Transphobia and prejudice (150)
- Uncategorized (13)
- Voice (2)
Blogroll
- Health Liberation Now!
- Trans Safety Network
- Science-Based Medicine
- Heather McNamara
- Jessica Kant
- Erin Reed
- Assigned Media
- TransLash
- Trans Data Library
- Southern Legal Counsel
- Transfeminine Science
- Stained Glass Woman
- TransAdvocate
- Dara Hoffman-Fox
- Growing Up Transgender
- Mermaids UK
- Center of Excellence for Transgender Health
Archives
Category Archives: COVID-19
Proxalutamide, a new antiandrogen, improves COVID-19 outcomes in trials of men and women
Previously: COVID-19 updates: From spironolactone to estrogen to GnRH antagonists (May 2020) Disclaimer: I am not a medical professional and this is not medical advice. The COVID-19 pandemic continues to be a rapidly evolving situation, and this information may be … Continue reading
2020’s hard lessons in public health pessimism
I was wrong. For the better part of a decade, my approach to communicating transgender medicine and science to the public has been premised on certain unexamined lay assumptions about what this wider audience struggles with and what they require … Continue reading
Posted in COVID-19, Personal, Transphobia and prejudice
Tagged personal, transphobia
Leave a comment
June COVID-19 update: Reassuring data on spironolactone and ACE2 risks
Disclaimer: I am not a medical professional and this is not medical advice. Our understanding of the pandemic is evolving rapidly; this information may be superseded by later and more conclusive findings. This article was last updated on June 30, 2020. … Continue reading
May COVID-19 updates: From spironolactone to estrogen to GnRH antagonists
Disclaimer: I am not a medical professional and this is not medical advice. Our understanding of the pandemic is evolving rapidly; this information may be superseded by later and more conclusive findings. This article was last updated on May 31, … Continue reading
Posted in COVID-19, Endocrinology, Health care
Tagged HRT, medicine, puberty blockers, science
1 Comment
The American Enterprise Institute’s statistical fumbles: Misusing linear regression for short-term COVID-19 trends
Disclaimer: I am not a medical professional, an expert in statistics or epidemiology, or a former FDA commissioner. Since the widespread outbreak of COVID-19 in the United States, certain conservative-leaning organizations and institutions – including federal and state governments – … Continue reading
Posted in COVID-19, Ethics, Health care, Replies, Statistics and demographics
Tagged science, statistics
Leave a comment
